Next Article in Journal
Physically Crosslinked Chondroitin Sulfate (CS)–Metal Ion (M: Fe(III), Gd(III), Zn(II), and Cu(II)) Particles for Versatile Applications and Their Biosafety
Next Article in Special Issue
Resveratrol Enhances Cytotoxic Effects of Cisplatin by Inducing Cell Cycle Arrest and Apoptosis in Ovarian Adenocarcinoma SKOV-3 Cells through Activating the p38 MAPK and Suppressing AKT
Previous Article in Journal
Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Previous Article in Special Issue
Propolis: A Detailed Insight of Its Anticancer Molecular Mechanisms
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 16
Issue 4
10.3390/ph16040482
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Antioxidants in Traditional Mexican Medicine and Their Applications as Antitumor Treatments

by
Karen M. Soto
1,*,
José de Jesús Pérez Bueno
2,
Maria Luisa Mendoza López
3,
Miguel Apátiga-Castro
4,
José M. López-Romero
1,
Sandra Mendoza
5 and
Alejandro Manzano-Ramírez
1,*
1
Centro de Investigaciones y de Estudios Avanzados del I.P.N., Unidad Querétaro, Querétaro 76230, Mexico
2
Centro de Investigación y Desarrollo Tecnológico en Electroquímica, S.C., Parque Tecnológico, Querétaro-Sanfandila, Pedro Escobedo, Santiago de Querétaro 76703, Mexico
3
Tecnológico Nacional de México, Instituto Tecnológico de Querétaro, Av. Tecnológico s/n, Esq. Mariano, Escobedo Colonia Centro, Santiago de Querétaro 76000, Mexico
4
Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, A.P. 1-1010, Querétaro 76230, Mexico
5
Research and Graduate Program in Food Science, Universidad Autónoma de Querétaro, Querétaro 76010, Mexico
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2023, 16(4), 482; https://doi.org/10.3390/ph16040482
Submission received: 15 February 2023 / Revised: 14 March 2023 / Accepted: 20 March 2023 / Published: 23 March 2023
(This article belongs to the Special Issue Molecular and Cellular Studies of Natural Antioxidants as Potential Therapeutics for Cancer)
Browse Figures
Review Reports Versions Notes

Abstract

:
Traditional medicine in Latin America and mainly in Mexico represents an essential alternative for treating different diseases. The use of plants as medicine is the product of a rich cultural tradition of the indigenous peoples, in which a great variety of species are used for the treatment of gastrointestinal, respiratory, and mental diseases and some other sicknesses; the therapeutic efficacy that they possess is due to the properties that derive from the active ingredients of plants principally antioxidants, such as phenolic compounds, flavonoids, terpenes, and tannins. An antioxidant is a substance that, at low concentrations, delays or prevents substrate oxidation through the exchange of electrons. Different methods are used to determine the antioxidant activity and the most commonly used are described in the review. Cancer is a disease in which some cells multiply uncontrollably and spread to other parts of the body, a process known as metastasis. These cells can lead to the formation of tumors, which are lumps of tissue that can be cancerous (malignant) or noncancerous (benign). Generally, the treatment of this disease consists of surgery, radiotherapy, or chemotherapy, which have side effects that decrease the quality of life of patients, so new treatments, focusing on natural resources such as plants, can be developed. This review aims to gather scientific evidence on the antioxidant compounds present in plants used in traditional Mexican medicine, specifically as antitumor treatment in the most common cancer types worldwide (e.g., breast, liver, and colorectal cancer).

1. Introduction

In recent years, cancer has become one of the most critical diseases in the world due to its high incidence and mortality rate. Based on the reported data, in 2020 more than 19.3 million new cancer cases were diagnosed and reported, leading to approximately 10 million deaths [1]. Cancer is characterized by an uncontrolled proliferation of abnormal cells and aberrant recognition of the immune system; it can occur in different body organs, such as the breast, prostate, colon, lung, lymph, blood, brain, and kidney. Cancer has various causes, but the most common are mutations or alterations in the expression patterns of proto-oncogenes, tumor suppressor genes, and genes involved in DNA repair, caused by environmental factors, such as exposure to radiation and pollutants and unhealthy lifestyles, including lack of physical activity, unbalanced diet, smoking [2,3,4]. The treatment depends on the type of cancer, the stage of the disease, and the patient’s ability to withstand the given therapy. However, the treatment is generally based on surgery and chemo- or radiation therapy to kill the cancer cells. Surgery causes functional deficiencies or esthetic discomfort; on the other hand, chemo- or radiotherapy is expensive and causes many side effects, including hematological toxicity, vomiting, appetite loss, delirium, diarrhea, fatigue, hair loss, pain, nausea, myelosuppression, and neurological, cardiac, pulmonary, and renal toxicity. These side effects reduce the quality life of the patients, and they have limited anti-cancer activity. Therefore, new treatment alternatives are sought, which minimize side effects and present excellent teratogenic effects against cancer cells [5].
Approximately 60% of principal drugs used in cancer treatments are produced with natural products, principally extracted from plants; medicinal plants have been used for many years in developing countries as the primary source of medical treatment, and developing nations are utilizing the benefits of naturally sourced compounds for therapeutic purposes [6,7]. In Mexico, ancient civilizations such as the Maya and the Aztecs developed some uses for medicinal plants, which were enriched by the conquering cultures. Currently, Mexico is one of the countries with the most significant number of plant species (31,000), and plants are also used as condiments and for ornamental, medicinal, and aromatic purposes. More than 3350 plants are part of the medicinal flora and play an essential role in public health in local communities [8]. Plants’ effects on different diseases are due to the compounds that they contain, mainly antioxidants such as phenolic acids, phenols, tannins, and anthocyanins [9].
In the present review, we present a summary of the literature that shows results from studies of the antitumor effects of antioxidants in Mexican plants used in traditional medicine.

2. Antioxidants

Antioxidants are natural or manufactured compounds that interact with free radicals and can neutralize them by donating electrons; they have been widely used as food additives to prevent lipid peroxidation and as adjuvants in reducing the risk of some diseases such as cancer and many chronic degenerative diseases such as coronary heart diseases, cardiovascular diseases, and aging [10]. Antioxidants can be classified as endogenous, exogenous, or synthetic; the first is produced naturally by the human body and consists of glutathione peroxidase, superoxide dismutase, and catalase, while non-enzymatic antioxidants are uric acid, lipoic acid, bilirubin, glutathione, and melatonin. Exogenous antioxidants are found in foods such as vegetables, fruits, and plants and consist of carotenoids, phenolic compounds, vitamins E, A, and C, and natural flavonoids or other compounds. Synthetic antioxidants correspond to petroleum-based compounds such as butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), propyl gallate (PG), and tert-butylhydroquinone (TBHQ) [11,12].

2.1. Antioxidant Activity and Capacity

Antioxidant activity refers to the constant reaction rate between a specific antioxidant and an oxidant. At the same time, capacity measures the amount of a given free radical scavenged by a sample. Many methods exist with highly sensitive and automated antioxidant capacity quantification technologies; some quantify the scavenging activity against certain types of free radicals or reactive oxygen species, reducing powder, or metal chelation [13]. Some of the most used are described below.

2.1.1. 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) Radical Scavenging Assay

The DPPH technique is based on the inactivation of the DPPH radical through the donation of electrons by antioxidants; the DPPH radical is a violet chromophore that changes to a yellow color when reduced; this change is measured at an absorbance of 527 nm. It is a simple technique that only requires the purchase of the radical and a spectrophotometer. Results are generally reported as mg equivalents of Trolox, the compound used as standard [13].

2.1.2. 2,2′-Azinobis (3-Ethylbenzothiazoline-6-Sulphonic Acid (ABTS•+)

This method quantifies the discoloration of the ABTS•+ radical due to its reduction to ABTS•+ by the action of antioxidants. The cationic radical ABTS+ is a bluish-green chromophore that absorbs at a wavelength of 734 nm and is generated by an oxidation reaction of ABTS•+ (ammonium 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonate) with potassium persulfate Thus, the degree of discoloration as a percentage of inhibition of the ABTS•+ radical is determined as a function of the concentration. Antioxidants can neutralize the radical cation ABTS•+ by either direct reduction via electron donation or by radical quenching via hydrogen atom donation. The antioxidant structure and pH of the medium generally determine the balance of these two mechanisms. The results are generally reported as TEAC (Trolox equivalent antioxidant capacity) [14].

2.1.3. Ferric Reducing Antioxidant Power Assay (FRAP)

FRAP is a colorimetric method that evaluates the ability of antioxidant compounds to reduce ferric iron (Fe3+) present in a complex with 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) up to the ferrous form (Fe2+); this method is carried out under acidic conditions (pH 3.6). In the presence of antioxidants, the ferric form of the compound iron-tripyridyl-triazine (Fe3+-TPTZ; yellow color) is reduced to the ferrous state (Fe2+-TPTZ; blue color). The Fe2+-TPTZ compound produces an intense blue coloration with a maximum absorption of 593 nm. The FRAP method is, therefore, a method that does not evaluate the neutralizing capacity of free radicals of the sample studied but rather its reducing capacity by electron transfer, contrary to the ABTS and DPPH methods [15].

2.1.4. Oxygen Radical Absorbance Capacity ORAC Assay

The assay measures the oxidative degradation of a fluorescent molecule (fluorescein) after it has been mixed with free radical generators such as azo compounds (2,20-azobis(2-amidinopropan) dihydrochloride). The azo derivatives are considered to produce peroxyl radicals by heating, which damages the fluorescent molecule, resulting in the loss of its fluorescence. Antioxidants protect the fluorescent molecule from oxidative degeneration. The degree of protection is quantified using a fluorometer. If an antioxidant is added to the test, the antioxidant reacts with the ROS, which delays the oxidation of fluorescein. Trolox and Vitamin E are used as standard [16].

2.1.5. Electrochemical Methods

Conventional methods such as DPPH, ABTS, and FRAP present different disadvantages because when they are monitored by UV spectroscopy, there may be factors that give an erroneous reading, such as interferences with chromophoric compounds present. Electrochemical methods based on the cyclic, differential pulse, square wave voltammetry, and coulometry represent an essential alternative; these techniques are sensitive, rapid, and simple, and they can directly measure the number of electrons transferred by an antioxidant. An electrochemist station and the corresponding electrodes are necessary to carry out these techniques [17,18].

2.2. Mexican Plants with Antioxidant Activity

Mexican plants represent a vast reservoir of compounds with excellent properties, capable of helping cure different diseases; for this reason, they have been used in traditional medicine since ancient times because they are cheap, widely available, and considered non-toxic since they are natural (it is important to emphasize that some plants can be toxic, depending on the dose consumed). The National Commission for the Knowledge and Use of Biodiversity (Conabio) [19] mentions the registry in the Mexican Institute of Social Security of 3000 species (of the 4000 that are estimated to exist in Mexico) of plants with medicinal attributes. These 4000 species represent 15% of the total Mexican flora (approximately 50,000 species). It specifies that only 5% of the total number of plants with medicinal attributes have been pharmacologically analyzed, and only 250 species are commercialized. Of these, 85% are extracted from the wild without sustainable management plans, and 80% of the Mexican population has used them [6,9,20].
Table 1 shows the values of antioxidant activity of some of the most used medicinal plants in Mexico for different sicknesses. The effect of the plants is related to a mixture of various compounds such as alcohols, esters, aldehydes, ketones, carbohydrates, terpenes, polyphenols, anthocyanins, tannins, and phenolic acids [21].
The antioxidant activity of plants is related to the different compounds found in all their parts, from roots, stems, leaves, and flowers (Figure 1). Generally, for measurement, extracts are made with different solvents, mainly ethanol and methanol. Some examples of this are the following: Annona muricata Linn., commonly known as soursop, is a plant used in traditional Mexican medicine to treat hypertension, diabetes, stomach pain, fever, parasitic infections, vomiting, cancer, and others conditions. Ethyl leaf fractions showed an excellent antimicrobial activity of 3964 ± 53 μmol Trolox eq g−1 in the ORAC test, and the principal components identified were chlorogenic and caffeic acids, procyanidins B2 and C1, (epi)catechin, quercetin, quercetin-hexosides, and kaempferol, a compound known as a potential antioxidant [22]. Castilleja tenuiflora Benth. (Orobanchaceae), commonly known as “Indian paintbrush,” is distributed in mountainous areas of the southern USA and Mexico; this plant is frequently used in the treatment of symptoms of various cancers, coughs, inflammation, and gastrointestinal disorders; its activity may be related to the biological activities of its secondary products, including iridoid glycosides, phenylethanoid glycosides), and flavonoids, compounds that allow it to possess an antioxidant activity of 161.74  ±  10.06 μmol Trolox/g dry weight in ABTS free-radical scavenging [23]. L. graveolens, Mexican oregano, has been commonly used in traditional medicine as a solid auxiliary against specific ailments linked to microorganism infections or inflammatory processes. The main components of oregano extracts have been associated with the capability of bacterial control, including against antibiotic-resistant strains; methanolic extracts of oregano showed an IC50 (inhibitory concentration 50) of 207.96 ± 1.43 in the DPPH assay, and the principal compounds are thymol, carvacrol, rosmarinic acid, naringenin, and some other phenolic compounds [24,25]. Tithonia diversifolia (Hemsl.) A. Gray (Asteraceae) is a plant native to Mexico and grows in parts of Africa, Australia, Asia, and America. Its flower extracts are traditionally used in treating diabetes, diarrhea, menstrual cramps, malaria, hematomas, hepatitis, hepatomas, and wounds. Flower extracts had an IC50 value of 265 μg/mL in the DPPH assay; different compounds were identified in these extracts, such as flavonoids, alkaloids, coumarins, tannins, and saponins [26,27]. Tagetes lucida, commonly named pericon, Mexican tarragon, and Mexican mint marigold, is an herbaceous, perennial, and endemic plant in Mexico and Guatemala. The infusion of this plant is widely used in traditional medicine to cure gastrointestinal disorders. It is reported to possess bactericidal and platelet antiaggregant activity and inhibitory effects on smooth-muscle contraction. The IC50 of the aqueous extract was 6.4 μg, and compounds such as gallic acid, quercetin, kaempferol, and rutin were present [28,29]. Tagetes erecta L. is widely commercialized as an ornamental plant for Dead Day in Mexico due to its showy orange and yellow flowers. In Mexico, it is known as the cempasuchil flower. The infusion of its flowers is used in traditional medicine to treat gastrointestinal diseases such as dyspepsia and diarrhea; it presents antimicrobial, antifungal, antioxidant, anti-inflammatory, and analgesic effects related to the presence of flavonoid compounds. In the ABTS assay, the antioxidant activity was 401.47 ± 3.35 mg TE/g of dry weight, and the principal components were phenolic acids such as caffeic acid, ellagic acid, coumaric acid, chlorogenic acid, protocatechuic acid, and rosmarinic acid, and flavonols such as rutin, apigenin, and kaempferol [8].
Table
Table 1. Antioxidant activity of different Mexican plants used in traditional medicine.
Table 1. Antioxidant activity of different Mexican plants used in traditional medicine.
PlantCommon NamePartDPPH
(mg TE/g)		ABTS
(mg TE/g)		TPC
(mg GAE/g)		Reference
A. muricataGuanabanaLeaves28.1 ± 4.4--79.4 ± 6.4 [22]
Castilleja tenuifloraCola de borregoAerial parts49.91 ± 1.80112.85 ± 7.0330.58 ± 2.39 [23]
L. graveolensOreganoLeaves81.00 ± 5.0--270.25 ± 4.1 [25]
Tithonia diversifoliaSunflowerLeaves217.2 ± 8.70--14.6 ± 0.64 [26]
Bougainvillea buttiana (Var. Orange and Rose)BugambiliaFlowers1683.6 ± 143.3--29.5 ± 0.05 [30]
Piper auritumYerba santaLeaves--14.82 ± 2.886.79 [31]
Justicia spicigeraMuicleLeaves880 ± 948480 ± 3788520 ± 497 [32]
Tribulus terrestrisAbrojoAerial~35--250 ± 1.17 [33]
Parthenium argentatum A. GrayGuayuleLeaves~21.3–27.4--~16–27 [34]
Parmentiera aculeata KunthCuajiloteFruit~160--~1980 [35]
Arctostaphylos pungensPingüicaFruit6214 ± 1328465 ± 124323.4 ±5.6 [36]
Thymus vulgarisTomilloLeavesIC50
13.4 μg/mL		IC50
40.03 μg/mL		~256 [37]
Eryngium carlinaeHierba del sapoInflorescence45.02 ± 0.31197.2 ± 754.32 ± 0.02 [38,39]
Bixa orellana L.AchioteSeed17.42 ± 0.45--62.08 ± 2.21 [40]
Acacia farnesianaHuizacheAerial 89 μmol TE/g ORAC3.4 g TE/g FRAP565 [41]
Taraxacum officinaleDiente de LeonLeaves and flowers0.950 ± 0.0021.132 ± 0.0120.535 ± 0.033 [42]
Tagetes erecta L.CempasuchilFlowers401.47 ± 3.35843.92 ± 4.44108.71 ± 1.13 [8,43]
Arnica montanaArnicaRoots ----116.9 ± 1.0 [44]
Ruta graveolens L.RudaLeaves67.59 ± 0.98--30.19 ± 0.16 [45]
Tagetes lucida CavPericonFlower-----12.7 ± 0.1 [46]
Anchusa officinalis L.Lengua de BueyFlower57.04 ± 1.08--104.03 ± 0.63 [47]
Passiflora incarnataPasifloraFlowerIC50 31.92 μg/mL---- [48]
Acalypha wilkesianaChirriteLeavesIC50 53.49 μg/mL--~50 [49]
TPC, total phenolic compounds; GAE, gallic acid equivalents; IC50, concentration that reduces the activity by 50%; TE, Trolox equivalent; (--) not shown.

3. Plants in the Treatment of Breast Cancer

Breast cancer (BC) is one of the most common cancers and is considered one of the leading causes of death in women. In 2020 it was estimated that 2,262,419 new cases were diagnosed, and 684,996 were reported. BC does not only occur in women; men also suffer from this type of cancer; in 2018, men’s mortality rates increased dramatically. Generally, BC is diagnosed early when the tumor can be extracted; however, 20–30% of patients suffer metastasis in different body parts. Different factors increase cancer risk, including genetic, reproductive, and lifestyle factors, hormonal imbalances, and other factors such as breast density, age, and change in circadian rhythm. The most common treatments for BC are chemotherapy, radiation, and principally surgery, where the breast is extracted entirely [50,51]. Figure 2 shows some plants used for breast cancer treatment.
Hypericum perforatum, known as San Juan in Mexico, is the most studied Hypericum species. It is known for its pharmacological antidepressant activities and antiviral and antibacterial properties. The aerial extracts’ principal component contains antioxidants such as quercetin, kaempferol, hyperiside, hypericin, catechins, apigenin, luteolin, and chlorogenic, caffeic, vanillic, p-hydroxybenzoic, and ferulic acids, and some condensed tannins. Abbas et al., 2016, studied the cytotoxic effect of hypericin, the principal component of H. perforatum, in the MCF-7 cell line derived from a patient with metastatic breast cancer. LD50 (lethal dose 50) of the hypericin in MTT assay was 5 μg/mL; the principal mechanism is the increment in the p53 expression and a decrease in bcl2, guardian cells in front of tumor formation, and anti-apoptotic genes [52,53].
Cestrum nocturnum L., lady of the night, or night jessamine, is an evergreen shrub from the family Solanaceae that grows in tropical and sub-tropical regions worldwide. In Mexico, it grows in the center and the Yucatan peninsula, where it is used in traditional medicine for its cytotoxic, hepatoprotective, and antitumor effects. Kumar et al., 2022, studied the compounds related to the cytotoxic-effect extracts. The results revealed that MFLCN (methanolic fraction obtained from ethyl acetate extract of leaf of Cestrum nocturnum) contained 33 flavonoids (4 in positive and 29 in negative ion modes) of different classes; some examples were kaempferol, apigenin, baicalin, quercetin, hyperoside, and vitexin. Furthermore, the cytotoxicity effect of the aqueous extract in breast carcinoma cell MCF-7 was investigated by Rashed et al. in 2018, getting a value of LD50 of 55.28 ± 4.87 μg/mL; the authors attributed the effect to the presence of large amounts of kaempferol, an antioxidant compound that has been highly related to cell death in different cancer cell lines [52,54].
Lophophora williamsii (LW), also known as peyote, devil’s root, dumpling cactus, or sacred mushroom, is a spineless, tufted, blue-green, button-like cactus. It grows wild in the center and north of Mexico, Nayarit, Querétaro, San Luis Potosí, Durango, Zacatecas, Nuevo León, and Baja California Norte, among other areas. It is used as an analgesic, stimulant, and antibiotic for its hallucinogenic properties. Franco et al., in 2017, studied the in vitro tumor cell toxicity in the MCF7 breast cancer cell line and another type of cancer (lymphoma, fibroblastoma). MCF7 was found to be the most sensitive cell line with a dose-response effect, which at 18 μg/mL, reduced cell viability by up to 1.3%; the study demonstrated that peyote extract was capable of stimulating lymphocyte proliferation and killing tumor cells [55,56].
Cordia boissieri, commonly known as Mexican anacahuita, is an ornamental shrub or tree up to 30 ft, with large, soft, dark leaves and large, showy, trumpet-shaped white flowers with yellow throats that are sometimes described as looking like crepe paper or chiffon. Different parts of this plant are used in traditional medicine; for example, the roots are used as emollients, and the flowers are used to treat coughs and colds, while the fruits and leaves are used to alleviate rheumatism and pulmonary illness. The components related to these effects depend on the area from which the extracts are obtained; the fruits are generally rich in kaempferol and hydroxy aldehyde, and in the flower extract, mainly (−)-spathulenol (19.1%) and (E)-caryophyllene (16.2%) have been identified [57]. Viveros-Valdez et al., in 2016, studied the cytotoxic effect of fruit extracted of C. boissieri against the MCF7 cancer breast cell line and obtained an IC50 of 310 ± 42 μg/mL; the cytotoxic effect is moderate compared to that of other fruit extracts, but it could be a good source of antioxidant compounds with an alpha-glucosidase inhibitory effect and antitumor effect in specific cancer types [58].
Bursera fagaroides var. fagaroides are a wild tree endemic to Mexico, known as aceitillo, copal, or cuajiote amarillo; its stem bark and exudates are both used in folk medicine to treat cuts and tumors; various studies have demonstrated its amoebicidal, immunomodulatory, and antitumoral activities. Peña-Morán et al., in 2016, studied the cytotoxicity effect of four compounds isolated from B. fagaroides, namely 51-demethoxy-peltatin-A-methylether (1), acetylpodophyllotoxin (2), 51-demethoxydeoxypodophyllotoxin (3), and 81-dehydroacetylpodophyllotoxin (4), compound 3 showed the lowest IC50 against MCF-7= 0.04 ± 0.01 μM; MDA-MB-23 = 0.145 ± 0.04 μM; and MCF-10A = 0.09 ± 0.009 μM [59,60].

4. Plants in the Treatment of Liver Cancer

Liver cancer is the fourth leading cause of cancer-related mortality worldwide, despite the liver being the sixth most common site of primary cancer. Hepatocellular carcinoma (HCC) accounts for 80–90% of primary liver cancers, and cholangiocarcinoma (CCA) accounts for 10–15%. Angiosarcoma and pediatric hepatoblastoma account for a relatively small proportion. Risk factors include hepatitis B virus, hepatitis C virus, fatty liver disease, alcohol-related cirrhosis, smoking, obesity, diabetes, iron overload, and various dietary factors because the liver plays a key role not only in the metabolism of macronutrients but also in detoxification and hormone production. Thus, the diet has measurable biological impacts on key pathways hypothesized to be involved in liver cancer risk [61,62,63]. One of the most important treatments for liver cancer is surgical resection or liver transplantation, depending on whether the patient is a suitable transplant candidate. However, most patients with liver cancer are diagnosed late, thereby excluding the patients from that treatment. In addition, chemotherapy and radiotherapy are generally ineffective for this type of cancer [64]. Table 2 summarize some of the plants used for the treatment of liver cancer.
Brickellia cavanillesii is a perennial herb endemic to Mexico and known commonly as “prodigiosa”, “atanasia amarga,” or “hamula”, among other names. It is generally commercially found in herbal stores and is used as a treatment for ulcers, dyspepsia, and diabetes (as a cheaper alternative to insulin). The chemical composition of B. cavanillesii plants consists of a glycoside named Brickellin, resin, essential oil, fat, tannin, coloring material, gum, starch, chlorophyll, and mineral salts. Eshiet et al., 2014, reported the presence of different antioxidant compounds in the ethanolic extract of B. cavanillesii; some of these were phenol, 2-methoxy-4-(1-propenyl); benzene, 1-(1, 5-dimethyl-4-hexenyl)-4-methyl-; phenol, 2-methoxy-; benzaldehyde, 3-hydroxy-4-methoxy-; 11, 13-eicosadienoic acid, methyl ester; maltol; phenol; and hydroquinone [65,66]. Viñas and Smith, in 2014, reported the potential cytotoxicity of Prodigiosa herbal tea on HepG2 cells (hepatocellular carcinoma from the liver tissue of a 15-year-old woman); they observed a dose- and time-dependent effect at a concentration of 200 mg/L, exhibiting excellent toxicity after 48 h that was associated with the regulatory mechanisms on GLUT2 (glucose transporter) expression and cDNA levels in HepG2 cells [67].
Maize (Zea mays L.) is one of Mexico’s primary food sources and is used to manufacture dry masa flours, chips, and tortillas. Different species of maize exist in Mexico, but native blue-pigmented maize has attracted extensive attention due to its nutraceutical perspective; the response of the blue color is the anthocyanins and other phenolic compounds mainly associated with the pericarp and the monolayered aleurone. Anthocyanins are essential nutraceutical compounds with high antioxidant capacity and are used to prevent or treat chronic degenerative diseases such as atherosclerosis, aging, diabetes, hypertension, inflammation, and cancer [68,69]. Urias-Lugo et al., in 2015, evaluated the cytotoxic effect of acidified and non-acidified extracts of blue maize on Hep2 cells (liver cancer); they were able to observe that at a concentration of 5 mg/mL, the acidified extract was capable of reducing cell viability by up to 70%. Furthermore, they observed a strong correlation between Cy3-Glu (cyanidin-3-O-glucoside) concentration with the cytotoxic effect [69].
Table
Table 2. Mexican medicinal plants with cytotoxic activity against different cell lines.
Table 2. Mexican medicinal plants with cytotoxic activity against different cell lines.
PlantPart of the PlantSolventCellular LineIC50
μg/mL		Reference
Rhoeo discolorLeavesMethanolHeLa70 ± 3.2 [70]
Roots67 ± 1.4
Lophocereus schottiiStemEthanolL5178Y7.8 [71]
Annona muricata LinnLeavesEthanol4T179.2 ± 0.2 [72]
Annona squoamosaSeedEthanolPC-313.08 [73]
SiHa16
Barringtonia racemosaFruitMethanolMCF-757.61 ± 2.24 [74]
Hibiscus sabdariffaFlowerMethanolMCF-7112.10 ± 3.97 [74,75]
Justicia spicigera SchltdlLeavesEthanolHeLa17 [76]
Tagetes lucida Cav.FlowersWaterCalu-1100 [46]
HepG2270
Dioon spinulosumLeavesEthanolMCF-722.5 [77]
HeLa21.8
Amphipterygium adstringensLeavesMethanolUACC-627.3 [78]
OVCAR-34.4
NCI-H46028
Lophophora williamsiiCactiMethanolC61.92 [55]
AmphipterygiumBarkMethanolHepG241.77 ± 6.18 [79]
Vero197.98 ± 4.71
Cissus incisaLeavesCHCl3/MeOHHeLa63 ± 7 [80]
PC343 ± 4
Cnidoscolus multilobus (Pax)LeavesEthanol/waterHeLa62 [81]
Capsicum chinenseLeavesMethanolMCF-70.38 ± 0.01 [82]
StemsMCF-72.01 ± 0.33
PedunclesMCF-70.46 ± 0.02
Semialarium mexicanum (Miers) MennegaRoot barkPetroleum etherMDA-MB-23155.5 [83]
MCF10A66.8
Asclepias subulataAerialEthanolHCT-1160.4 [84]
Agave lechuguilla TorrLeavesEthanolMCF-7>150 [85]
HeLa89
Vero126
R. communisAerialMethanolVero34.8 [86]
Ether326.8
Hippocratea celastroidesLeavesEthanolMCF-72.29 [87]
Stem2.57
Root2.81
Carica papaya L.FlowerEthanolVero62.5 [88]
Smilax aspera LRootsAcetoneMDA-MB-231695 [89]
A549535
OVCAR3117
Argemone mexicana Linn.WholeMethanolMCF-795.50 ± 3.69 [90]
HeLa38.01 ± 1.77
Phaseolus vulgaris L.BeanWater/methanolCaco281.2 [91]
IC50, inhibitory concentration 50 (concentration needed to inhibit 50% cellular viability); HeLa (cervical carcinoma); L5178Y, lymphoblast cell line; 4T1, stage IV human breast cancer; PC3, stage V prostatic adenocarcinoma; SiHa, carcinoma of the uterus; MCF7, breast cancer; Calu-1, lung epidermoid carcinoma; HepG2, hepatocellular carcinoma; UACC-62, pancreatic cancer metastatic; OVCAR-3, adenocarcinoma of the ovary; NCI-H460, lung carcinoma; C6, the brain of a rat with glioma; Vero, kidney tissue; MDA-MB-231, human breast cancer; MCF10A, fibrocystic breasts; A549, lung cancer; Caco2, colorectal adenocarcinoma.

5. Plants in the Treatment of Colorectal Cancer

Colorectal cancer (CRC) is one of the most prevalent and incident cancers worldwide; it is the second most common adult cancer in women, the third most common in men, and the second cause of cancer-related death worldwide. There were over 1.8 million new cases in 2018 in developed countries. In the United States, 148,000 new cases and 53,200 deaths per year are estimated; in Mexico, according to the Mexican Institute of Social Security (IMMS), it is estimated that 15,000 new cases are diagnosed each year. If colorectal cancer is detected in the early stage, it is curable. Therefore, early detection can reduce the mortality rate of colorectal cancer. However, approximately 25% of CRC patients with the advanced-stage disease will develop metastasis at diagnosis [92,93,94]. Different factors are related to cancer incidence, including genetic and environmental factors, and lifestyle factors such as physical inactivity, sedentary behavior, and excessive caloric intake, leading to energy imbalance, progressively leading to obesity. Generally, treating patients with colon cancer includes surgery (segmental colon resection), chemotherapy, and radiotherapy, but some plants are used for the treatment of this disease (Table 2; Figure 2) [95].
Thalassia testudinum is a seagrass that forms dense, extensive pastures in the Mexican Caribbean; it presents a dense underground network of roots and rhizomes that serves as a support and storage system for a series of short vertical shoots, each one having two to eight trap-shaped leaf blades, they are the leading food of green turtles. Chelonia mydas. T. testudinum has been studied for its beneficial properties, such as anti-inflammatory, cytoprotective, antioxidative, and neuroprotective properties related to the high polyphenolic content [96]. Delgado-Roche et al., 2020, studied the activity of the polyphenolic fraction of T. testudinum against a colorectal cancer cell line (HCT15) and obtained an IC50 value of 22.47 ± 1.30 μg/mL after 48 h of treatment, with ROS overproduction and pro-apoptotic effects [97].
Annona muricata is a tropical, fruit-bearing tree of the family Annonaceae found in South America; in Mexico, the top producing states are Nayarit, Colima, and Michoacan. A. muricata, commonly known as soursop, graviola, or guanabana, has large, glossy, dark green leaves. The aerial parts of guanabana have several applications: fruits have been widely used as a food ingredient, while several preparations, especially decoctions of the bark, fruits, leaves, pericarp, seeds, and roots, have been extensively used in traditional medicine to treat multiple ailments including cancers, diabetes, arthritis, hypertension, snake bite, diarrhea, headache, and malaria [98]. Daddiouaissa et al., 2021, investigated the effect of a pulp extract of guanabana fruit on the metabolomics behavior of colon cancer cells (HT29) using an untargeted GC-TOFMS-based metabolic profiling. Pathway analysis of metabolomic profiles revealed an alteration of many metabolic pathways, including amino acid metabolism, aerobic glycolysis, urea cycle, and ketone body metabolism that contribute to energy metabolism and cancer cell proliferation, with the conclusion that the pulp extract is a promising anticancer agent [99]. Moghadamtousi et al., 2014, investigated the anticancer properties of ethyl acetate extract of A. muricata leaves on HT-29 and HCT-116 colon cancer cells. The extract exhibited significant cytotoxic effects on HCT-116 and HT-29 cells with an IC50 value of 11.43 ± 1.87 mg/mL and 8.98 ± 1.24 mg/mL against HT-29 and HCT-116 cells, respectively. The mechanistic effect in cancer cells was the excessive accumulation of ROS followed by disruption of MMP, cytochrome c leakage, and activation of the initiator and executioner caspases in both cellular lines [100].
Opuntia ficus-indica (L.) Mill. is a dicotyledonous angiosperm tree-like cactus belonging to the family Cactaceae (subfamily Opuntiodeae, Genus Opuntia), also known as prickly pear, and originating from Mexico. However, it can be found in all American hemispheres and grows worldwide, such as in Africa, Australia, and the Mediterranean basin. Several ingredients and bioactive compounds that show pharmacological properties have been identified in the fruit, including carbohydrates; lipids; proteins with their specific amino acids; vitamins; minerals; and phenolic compounds, in particular, phenolic acids (hydroxycinnamic acids and hydroxybenzoic acids); flavonoids; lignins; and stilbenes. This plant is used in traditional medicine to treat diabetes, high cholesterol, obesity, and hangovers. It is also known for its antiviral and anti-inflammatory properties [101,102,103]. Antunes-Ricardo et al., in 2014, evaluated the effect of O. ficus alkaline extracts and purified isorhamnetin glycosides (obtained from the extracts) against two different human colon cancer cells (HT-29 and Caco2). The OFI extracts and purified isorhamnetin glycosides were more cytotoxic against HT-29 cells than Caco2 cells. The cytotoxic activity depends on the extraction time and is related to the activation of Caspase 3/7 and apoptosis [104]. In 2021 the authors evaluated the effects of Opuntia ficus-indica extract (OFI-E) and its glycoside isorhamnetin-3-O-glucosylrhamnoside (IGR) on an HT29 cell line and the growth of human colorectal adenocarcinoma cells as well as in a xenografted-immunosuppressed mice model. The extract increased apoptosis induction, ROS production, and a G0/G1 cell cycle arrest in HT29 cells. In the mice, the extract and IGR reduced the tumor growth rate through the overexpression of cleaved Caspase-9, Hdac11, and Bai1 proteins and reduced the myeloperoxidase activity and total cholesterol levels [105].
Punica granatum, known as cordelina Granada, red pomegranate, or pomegranate, is a small tree from 3 to 6 m high with a semi-woody stem. The leaves are shiny and more prolonged than wide and reddish-green. It has showy red or orange flowers with numerous thread-like stamens. The fruits are globose and red with a kind of crown at one end, with many fleshy, edible seeds that are red. It is characterized by its antioxidant, antihypertensive, and chemopreventive properties in different tissues due to its content of phenolic compounds present in different parts of the plant. For example, the pericarp of the fruit is a rich source of bioactive molecules, such as ellagitannins, polyphenols, flavonoids (luteolin, kaempferol, and quercetin), and anthocyanidins (delphinidin, cyanidin, and pelargonidin); the juice presents a high content of anthocyanins and the leaves and flowers contain tannins and flavones such as apigenin and gallic acid [106,107]. Rodrigues et al., 2020 evaluated the antiproliferative activity of a fast one-step solid–liquid extract of pomegranate grains in HT29 cells; the results showed an IC50 value of 318 μg/mL related to the presence of antioxidant compounds such as gallic acid, caffeic acid, catechin, and epicatechin gallate [108].

6. Future Perspectives of Medicinal Plant Antioxidants in Cancer Therapy

Cancer is one of the most critical public health problems worldwide due to its high incidence and mortality rate. The principal treatments are chemotherapy and radiotherapy, although both are associated with several side effects because the action to kill cells is not specifically only for cancer cells. Developing an effective treatment with anticancer properties and minor adverse effects is necessary. Currently, it is common for patients to choose a non-traditional anticancer treatment in addition to conventional treatment. Natural compounds with anticancer properties, such as antioxidants, can kill transformed or cancerous cells without being toxic to healthy cells. Antioxidants are bioactive molecules widely distributed in the plant kingdom. They have been used in traditional Mexican medicine since ancient times to treat different sicknesses, including cancer, as observed in the reports cited in this bibliographical review [109,110,111,112]. However, it is essential to ask ourselves what is missing for the plants used in traditional Mexican medicine to be used as a medicine to treat cancer. It is necessary to elucidate the mechanism of action of compounds that eliminate cancer cells, not only in cell lines but also in preclinical and clinical studies in animal models and humans, as well as carrying out toxicological studies of the side effects that may exist after the consumption of these plants. In the same way, it is essential to emphasize that most of the reported studies used concentrated extracts of the plants, which were made with different solvents that may not be allowed for human consumption. In addition, there is the fact that when dealing with living materials such as plants, we may observe a difference in the number of antioxidant compounds, as well as in the cytotoxic activity, depending on the year of harvest, place of planting, and even the climate that has prevailed during its growth. For these reasons, it is of the utmost importance that we carry out studies of the chemical composition of the plants and, if possible, the identification and isolation of the compounds responsible for the activity, which could promote a better understanding of the mechanism of action and the compounds’ potential use as a treatment. Another point to consider is the bioavailability and bioaccessibility studies of the compounds present in plants since, once in the human body, these parameters can decrease, so incorporating these compounds in controlled-release systems would be a great help in allowing their delivery and protecting them from environmental factors. Even with the aforementioned, antioxidant compounds from Mexican medicinal plants represent a viable alternative for developing new treatments against different types of cancer, and it is an area that requires further study.

7. Conclusions

This review presents scientific evidence of the antioxidants present in Mexican medicinal plants used for cancer treatment; the information collected suggests that most studies have been carried out using aqueous, ethanolic, and methanolic extracts. They have been tested in cell lines of different types of cancer, and the activity is mainly attributed to the generation of ROS, activation of caspase 3/7, and induction of apoptosis, which is related to the presence of different antioxidant compounds in plants. On the other hand, further efforts are required to clarify and understand the mechanisms of action through which traditional plants and their antioxidant compounds reduce the cellular viability of cancer cells; however, the evidence confirms the role of plants as an excellent source of antioxidant compounds able to fight cancer and other sicknesses and support the use of Mexican medicinal plants.

Author Contributions

Conceptualization, K.M.S. and A.M.-R.; formal analysis, M.A.-C.; investigation, S.M. and M.L.M.L.; writing—original draft preparation, K.M.S.; writing—review and editing, A.M.-R. and J.d.J.P.B.; funding acquisition, J.M.L.-R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science and Technology Council of the State of Queretaro, project number 45/ESP701/2022.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ferlay, J.; Colombet, M.; Soerjomataram, I.; Parkin, D.M.; Piñeros, M.; Znaor, A.; Bray, F. Cancer Statistics for the Year 2020: An Overview. Int. J. Cancer 2021, 149, 778–789. [Google Scholar] [CrossRef] [PubMed]
  2. Yin, W.; Wang, J.; Jiang, L.; James Kang, Y. Cancer and Stem Cells. Exp. Biol. Med. 2021, 246, 1791–1801. [Google Scholar] [CrossRef]
  3. Berger, M.F.; Mardis, E.R. The Emerging Clinical Relevance of Genomics in Cancer Medicine. Nat. Rev. Clin. Oncol. 2018, 15, 353–365. [Google Scholar] [CrossRef]
  4. Chhikara, B.S.; Parang, K. Global Cancer Statistics 2022: The Trends Projection Analysis. Chem. Biol. Lett. 2023, 10, 451. [Google Scholar]
  5. Soto, K.M.; Mendoza, S.; López-Romero, J.M.; Gasca-Tirado, J.R.; Manzano-Ramírez, A. Gold Nanoparticles: Synthesis, Application in Colon Cancer Therapy and New Approaches—Review. Green Chem. Lett. Rev. 2021, 14, 663–676. [Google Scholar] [CrossRef]
  6. Greenwell, M.; Rahman, P.K.S.M. Medicinal Plants: Their Use in Anticancer Treatment. Int. J. Pharm. Sci. Res. 2015, 6, 4103–4112. [Google Scholar] [CrossRef] [PubMed]
  7. Laha, D.; Nilubol, N.; Boufraqech, M. New Therapies for Advanced Thyroid Cancer. Front. Endocrinol. 2020, 11, 82. [Google Scholar] [CrossRef] [PubMed]
  8. Soto, K.M.; López-Romero, J.M.; Mendoza, S.; Peza-Ledesma, C.; Rivera-Muñoz, E.M.; Velazquez-Castillo, R.R.; Pineda-Piñón, J.; Méndez-Lozano, N.; Manzano-Ramírez, A. Rapid and Facile Synthesis of Gold Nanoparticles with Two Mexican Medicinal Plants and a Comparison with Traditional Chemical Synthesis. Mater. Chem. Phys. 2023, 295, 127109. [Google Scholar] [CrossRef]
  9. Martíınez, C.C.; Gómez, M.D.; Oh, M.S. Use of Traditional Herbal Medicine as an Alternative in Dental Treatment in Mexican Dentistry: A Review. Pharm. Biol. 2017, 55, 1992–1998. [Google Scholar] [CrossRef] [Green Version]
  10. Gulcin, İ. Antioxidants and Antioxidant Methods: An Updated Overview. Arch. Toxicol. 2020, 94, 651–715. [Google Scholar] [CrossRef] [Green Version]
  11. Salazar, R.; Pozos, M.E.; Cordero, P.; Perez, J.; Salinas, M.C.; Waksman, N. Determination of the Antioxidant Activity of Plants from Northeast Mexico. Pharm. Biol. 2008, 46, 166–170. [Google Scholar] [CrossRef] [Green Version]
  12. Mateos-Maces, L.; Chávez-Servia, J.L.; Vera-Guzmán, A.M.; Aquino-Bolaños, E.N.; Alba-Jiménez, J.E.; Villagómez-González, B.B. Edible Leafy Plants from Mexico as Sources of Antioxidant Compounds, and Their Nutritional, Nutraceutical and Antimicrobial Potential: A Review. Antioxidants 2020, 9, 541. [Google Scholar] [CrossRef] [PubMed]
  13. Shahidi, F.; Zhong, Y. Measurement of Antioxidant Activity. J. Funct. Foods 2015, 18, 757–781. [Google Scholar] [CrossRef]
  14. Karadag, A.; Ozcelik, B.; Saner, S. Review of Methods to Determine Antioxidant Capacities. Food Anal. Methods 2009, 2, 41–60. [Google Scholar] [CrossRef]
  15. Gruszycki, M.R.; Valenzuela, G.M.; Báez, M.; Leguiza, P.D.; Gruszycki, A.E.; Alba, D.A. Evaluación de La Actividad Antioxidante En Extractos Hidroalcohólicos de Portulaca Oleracea L. Rev. Colomb. Cienc. Quím.-Farm. 2019, 48, 425–435. [Google Scholar] [CrossRef]
  16. Borlinghaus, J.; Reiter, J.; Ries, M.; Gruhlke, M.C.H. Screening Procedures and Tests for Antioxidants. In Pathology: Oxidative Stress and Dietary Antioxidants; Elsevier: Amsterdam, The Netherlands, 2020; pp. 389–395. ISBN 9780128159729. [Google Scholar]
  17. Hoyos-Arbeláez, J.; Vázquez, M.; Contreras-Calderón, J. Electrochemical Methods as a Tool for Determining the Antioxidant Capacity of Food and Beverages: A Review. Food Chem. 2017, 221, 1371–1381. [Google Scholar] [CrossRef]
  18. Haque, M.A.; Morozova, K.; Ferrentino, G.; Scampicchio, M. Electrochemical Methods to Evaluate the Antioxidant Activity and Capacity of Foods: A Review. Electroanalysis 2021, 33, 1419–1435. [Google Scholar] [CrossRef]
  19. Secretaría de Medio Ambiente y Recursos Naturales. Available online: https://Www.Gob.Mx/Semarnat/Articulos/Plantas-Medicinales-de-Mexico?Idiom=es (accessed on 23 February 2023).
  20. Pérez-González, M.Z.; Jiménez-Arellanes, M.A. Biotechnological Processes to Obtain Bioactive Secondary Metabolites from Some Mexican Medicinal Plants. Appl. Microbiol. Biotechnol. 2021, 105, 6257–6274. [Google Scholar] [CrossRef]
  21. Chamorro-Cevallos, G.; Mojica-Villegas, M.A.; García-Martínez, Y.; Pérez-Gutiérrez, S.; Madrigal-Santillán, E.; Vargas-Mendoza, N.; Morales-González, J.A.; Cristóbal-Luna, J.M. A Complete Review of Mexican Plants with Teratogenic Effects. Plants 2022, 11, 1675. [Google Scholar] [CrossRef]
  22. Justino, A.B.; Miranda, N.C.; Franco, R.R.; Martins, M.M.; da Silva, N.M.; Espindola, F.S. Annona Muricata Linn. Leaf as a Source of Antioxidant Compounds with in Vitro Antidiabetic and Inhibitory Potential against α-Amylase, α-Glucosidase, Lipase, Non-Enzymatic Glycation and Lipid Peroxidation. Biomed. Pharmacother. 2018, 100, 83–92. [Google Scholar] [CrossRef]
  23. Valdez-Tapia, R.; Capataz-Tafur, J.; López-Laredo, A.R.; Trejo-Espino, J.L.; Trejo-Tapia, G. Effect of Immersion Cycles on Growth, Phenolics Content, and Antioxidant Properties of Castilleja Tenuiflora Shoots. In Vitr. Cell. Dev. Biol.-Plant 2014, 50, 471–477. [Google Scholar] [CrossRef]
  24. Bautista-Hernández, I.; Aguilar, C.N.; Martínez-ávila, G.C.G.; Torres-León, C.; Ilina, A.; Flores-Gallegos, A.C.; Kumar Verma, D.; Chávez-González, M.L. Mexican Oregano (Lippia Graveolens Kunth) as Source of Bioactive Compounds: A Review. Molecules 2021, 26, 5156. [Google Scholar] [CrossRef]
  25. Martínez-Rocha, A.; Puga, R.; Hernández-Sandoval, L.; Loarca-Piña, G.; Mendoza, S. Antioxidant and Antimutagenic Activities of Mexican Oregano (Lippia Graveolens Kunth). Plant Foods Hum. Nutr. 2008, 63, 1–5. [Google Scholar] [CrossRef]
  26. Pretti, I.R.; da Luz, A.C.; Jamal, C.M.; Batitucci, M.D.C.P. Variation of Biochemical and Antioxidant Activity with Respect to the Phenological Stage of Tithonia Diversifolia Hemsl. (Asteraceae) Populations. Ind. Crops Prod. 2018, 121, 241–249. [Google Scholar] [CrossRef]
  27. Pantoja Pulido, K.D.; Colmenares Dulcey, A.J.; Isaza Martínez, J.H. New Caffeic Acid Derivative from Tithonia Diversifolia (Hemsl.) A. Gray Butanolic Extract and Its Antioxidant Activity. Food Chem. Toxicol. 2017, 109, 1079–1085. [Google Scholar] [CrossRef] [PubMed]
  28. Aquino, R.; Cáceres, A.; Morelli, S.; Rastrelli, L. An Extract of Tagetes Lucida and Its Phenolic Constituents as Antioxidants. J. Nat. Prod. 2002, 65, 1773–1776. [Google Scholar] [CrossRef] [PubMed]
  29. Céspedes, C.L.; Avila, J.G.; Martínez, A.; Serrato, B.; Calderón-Mugica, J.C.; Salgado-Garciglia, R. Antifungal and Antibacterial Activities of Mexican Tarragon (Tagetes Lucida). J. Agric. Food Chem. 2006, 54, 3521–3527. [Google Scholar] [CrossRef]
  30. Petricevich, V.L.; Cedillo-Cortezano, M.; Abarca-Vargas, R. Chemical Composition, Antioxidant Activity, Cytoprotective and In Silico Study of Ethanolic Extracts of Bougainvillea × Buttiana (Var. Orange and Rose). Molecules 2022, 27, 6555. [Google Scholar] [CrossRef] [PubMed]
  31. Conde-Hernández, L.A.; Guerrero-Beltrán, J.Á. Total Phenolics and Antioxidant Activity of Piper Auritum and Porophyllum Ruderale. Food Chem. 2014, 142, 455–460. [Google Scholar] [CrossRef]
  32. Baqueiro-Peña, I.; Guerrero-Beltrán, J. Physicochemical and Antioxidant Characterization of Justicia Spicigera. Food Chem. 2017, 218, 305–312. [Google Scholar] [CrossRef]
  33. Hammoda, H.M.; Ghazy, N.M.; Harraz, F.M.; Radwan, M.M.; ElSohly, M.A.; Abdallah, I.I. Chemical Constituents from Tribulus Terrestris and Screening of Their Antioxidant Activity. Phytochemistry 2013, 92, 153–159. [Google Scholar] [CrossRef] [PubMed]
  34. Jara, F.M.; Carrión, M.E.; Angulo, J.L.; Latorre, G.; López-Córcoles, H.; Zalacain, A.; Hurtado de Mendoza, J.; García-Martínez, M.M.; Carmona, M. Chemical Characterization, Antioxidant Activity and Morphological Traits in the Leaves of Guayule (Parthenium Argentatum A. Gray) and Its Hybrids. Ind. Crops Prod. 2022, 182, 114927. [Google Scholar] [CrossRef]
  35. Cristina, S.R.; Noemi, N.L.V.; Gabriela, C.B.M.; Gilber, V.G.; Alberto, V.L.A. Antimicrobial Activity, Phenolic and Antioxidant Content of Extracts from Cuajilote (Parmentiera Aculeata Kunth) Fruits at Different Degrees of Ripening. J. Mex. Chem. Soc. 2021, 65, 161–169. [Google Scholar] [CrossRef]
  36. Navarro-Cortez, R.; Tovar-Jímenez, X.; Mora-Rochín, S.; Rochín-Medina, J.; Aguayo-Rojas, J.C.F. Minerales, Capacidad Antioxidante y Antidepresiva de Pingüica (Arctostaphylos Pungens). Acta Univ. Multidiscip. Sci. J. 2022, 32, 1–15. [Google Scholar]
  37. Köksal, E.; Bursal, E.; Gülçin, İ.; Korkmaz, M.; Çağlayan, C.; Gören, A.C.; Alwasel, S.H. Antioxidant Activity and Polyphenol Content of Turkish Thyme (Thymus Vulgaris) Monitored by Liquid Chromatography and Tandem Mass Spectrometry. Int. J. Food Prop. 2017, 20, 514–525. [Google Scholar] [CrossRef] [Green Version]
  38. García-Cerrillo, D.; Noriega-Cisneros, R.; Peña-Montes, D.; Huerta-Cervantes, M.; Ríos-Silva, M.; Salgado-Garciglia, R.; Montoya-Pérez, R.; Saavedra-Molina, A. Antioxidant Effects of Eryngium Carlinae in Diabetic Rats. Asian J. Appl. Sci. 2018, 6. [Google Scholar] [CrossRef] [Green Version]
  39. Alvarado, T.D.; Mariezcurrena Berasain, M.D.; Salem, A.Z.M.; Pinzón Martínez, D.L. Antimicrobial and Antioxidant Activities of Two Medicinal Plants Cuphea Aequipetala Var. Hispida (Cav.) Koehne and Eryngium Comosum Delaroche F Against Bacteria Related to Equine Infections. J. Equine Vet. Sci. 2020, 94, 103269. [Google Scholar] [CrossRef]
  40. Van Cuong, T.; Chin, K.B. Effects of Annatto (Bixa Orellana L.) Seeds Powder on Physicochemical Properties, Antioxidant and Antimicrobial Activities of Pork Patties during Refrigerated Storage. Korean J. Food Sci. Anim. Resour. 2016, 36, 476–486. [Google Scholar] [CrossRef]
  41. Claudia, D.P.; Mario, C.H.; Arturo, N.O.; Noel, M.C.O.; Antonio, N.C.; Teresa, R.A.; Gerardo, L.T.Z.; Margarita, D.M.; Alejandra, Á.I.M.; Rosalina, C.M.Y.; et al. Phenolic Compounds in Organic and Aqueous Extracts from Acacia Farnesiana Pods Analyzed by ULPS-ESI-Q-Oa/TOF-MS. In Vitro Antioxidant Activity and Anti-Inflammatory Response in CD-1 Mice. Molecules 2018, 23, 2386. [Google Scholar] [CrossRef] [Green Version]
  42. Miłek, M.; Marcinčáková, D.; Legáth, J. Polyphenols Content, Antioxidant Activity, and Cytotoxicity Assessment of Taraxacum Officinale Extracts Prepared through the Micelle-Mediated Extraction Method. Molecules 2019, 24, 1025. [Google Scholar] [CrossRef] [Green Version]
  43. Burlec, A.F.; Pecio, Ł.; Kozachok, S.; Mircea, C.; Corciovă, A.; Vereştiuc, L.; Cioancă, O.; Oleszek, W.; Hăncianu, M. Phytochemical Profile, Antioxidant Activity, and Cytotoxicity Assessment of Tagetes Erecta L. Flowers. Molecules 2021, 26, 1201. [Google Scholar] [CrossRef] [PubMed]
  44. Gawlik-Dziki, U.; Świeca, M.; Sugier, D.; Cichocka, J. Comparison of in vitro lipoxygenase, xanthine oxidase inhibitory and antioxidant activity of Arnica Montana and Arnica Chamissonis tinctures. Acta Sci. Pol. Hortorum Cultus 2011, 10, 15–27. [Google Scholar]
  45. Pavić, V.; Flačer, D.; Jakovljević, M.; Molnar, M.; Jokić, S. Assessment of Total Phenolic Content, in Vitro Antioxidant and Antibacterial Activity of Ruta Graveolens L. Extracts Obtained by Choline Chloride Based Natural Deep Eutectic Solvents. Plants 2019, 8, 69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Caballero-Gallardo, K.; Quintero-Rincón, P.; Stashenko, E.E.; Olivero-Verbel, J. Photoprotective Agents Obtained from Aromatic Plants Grown in Colombia: Total Phenolic Content, Antioxidant Activity, and Assessment of Cytotoxic Potential in Cancer Cell Lines of Cymbopogon Flexuosus L. and Tagetes Lucida Cav. Essential Oils. Plants 2022, 11, 1693. [Google Scholar] [CrossRef]
  47. Boskovic, I.; Đukić, D.A.; Maskovic, P.; Mandić, L.; Perovic, S. Phytochemical Composition and Antimicrobial, Antioxidant and Cytotoxic Activities of Anchusa Officinalis L. Extracts. Biologia 2018, 73, 1035–1041. [Google Scholar] [CrossRef]
  48. Ingale, S.P.; Kasture, S.B. Antioxidant and Antiparkinsonian Activity of Passiflora Incarnata Leaves. Orient. Pharm. Exp. Med. 2014, 14, 231–236. [Google Scholar] [CrossRef]
  49. Omotayo, M.; Akoro, S.; Avungbeto, M.; Uwakwe, H. Evaluation of Free Radical Scavenging and Antibacterial Activity of Acalypha Wilkesiana and Terminalia Catappa Methanolic Leaf Extracts. Microbiol. Res. J. Int. 2017, 19, 1–9. [Google Scholar] [CrossRef]
  50. Alharbi, K.S.; Almalki, W.H.; Makeen, H.A.; Albratty, M.; Meraya, A.M.; Nagraik, R.; Sharma, A.; Kumar, D.; Chellappan, D.K.; Singh, S.K.; et al. Role of Medicinal Plant-Derived Nutraceuticals as a Potential Target for the Treatment of Breast Cancer. J. Food Biochem. 2022, 46, e14387. [Google Scholar] [CrossRef]
  51. Yap, K.M.; Sekar, M.; Seow, L.J.; Gan, S.H.; Bonam, S.R.; Mat Rani, N.N.I.; Lum, P.T.; Subramaniyan, V.; Wu, Y.S.; Fuloria, N.K.; et al. Mangifera Indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action. Breast Cancer Targets Ther. 2021, 13, 471–503. [Google Scholar] [CrossRef]
  52. Alahmad, A.; Alghoraibi, I.; Zein, R.; Kraft, S.; Dräger, G.; Walter, J.G.; Scheper, T. Identification of Major Constituents of Hypericum Perforatum L. Extracts in Syria by Development of a Rapid, Simple, and Reproducible HPLC-ESI-Q-TOF MS Analysis and Their Antioxidant Activities. ACS Omega 2022, 7, 13475–13493. [Google Scholar] [CrossRef]
  53. Mirmalek, S.A.; Azizi, M.A.; Jangholi, E.; Yadollah-Damavandi, S.; Javidi, M.A.; Parsa, Y.; Parsa, T.; Salimi-Tabatabaee, S.A.; Ghasemzadeh Kolagar, H.; Alizadeh-Navaei, R. Cytotoxic and Apoptogenic Effect of Hypericin, the Bioactive Component of Hypericum Perforatum on the MCF-7 Human Breast Cancer Cell Line. Cancer Cell Int. 2016, 16, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Rashed, K.N.; Ćirič, A.; Glamočlija, J.; Calhelha, R.C.; Ferreira, I.C.F.R.; Soković, M. Identification of the Bioactive Constituents and the Antibacterial, Antifungal and Cytotoxic Activities of Different Fractions from Cestrum Nocturnum L. Jordan J. Biol. Sci. 2018, 11, 273–279. [Google Scholar]
  55. Franco-Molina, M.A.; Santana-Krímskaya, S.E.; Madrigal-De-león, L.M.; Coronado-Cerda, E.E.; Zárate-Triviño, D.G.; Hernández-Martínez, S.P.; García-Coronado, P.L.; Rodríguez-Padilla, C. Evaluation of the Cytotoxic and Immunogenic Potential of Temozolamide, Panobinostat, and Lophophora Williamsii Extract against C6 Glioma Cells. EXCLI J. 2021, 20, 614–624. [Google Scholar] [CrossRef] [PubMed]
  56. Franco-Molina, M.; Gomez-Flores, R.; Tamez-Guerra, P.; Tamez-Guerra, R.; Castillo-Leon, L.; Rodríguez-Padilla, C. In Vitro Immunopotentiating Properties and Tumour Cell Toxicity Induced by Lophophora Williamsii (Peyote) Cactus Methanolic Extract. Phytother. Res. 2003, 17, 1076–1081. [Google Scholar] [CrossRef]
  57. Owis, A.I.; Abo-Youssef, A.M.; Osman, A.H. Leaves of Cordia Boissieri A. DC. As a Potential Source of Bioactive Secondary Metabolites for Protection against Metabolic Syndrome-Induced in Rats. Z. Nat. 2017, 72, 107–118. [Google Scholar] [CrossRef]
  58. Viveros-Valdez, E.; Jaramillo-Mora, C.; Oranday-Cárdenas, A.; Morán-Martínez, J.; Carranza-Rosales, P. Antioxidant, Cytotoxic and Alpha-Glucosidase Inhibition Activities from the Mexican Berry “Anacahuita” (Cordia boissieri). Arch. Latinoam. Nutr. 2016, 66, 211–218. [Google Scholar]
  59. Peña-Morán, O.A.; Villarreal, M.L.; Álvarez-Berber, L.; Meneses-Acosta, A.; Rodríguez-López, V. Cytotoxicity, Post-Treatment Recovery, and Selectivity Analysis of Naturally Occurring Podophyllotoxins from Bursera Fagaroides Var. Fagaroides on Breast Cancer Cell Lines. Molecules 2016, 21, 1013. [Google Scholar] [CrossRef] [Green Version]
  60. Rojas-Sepúlveda, A.M.; Mendieta-Serrano, M.; Mojica, M.Y.A.; Salas-Vidal, E.; Marquina, S.; Villarreal, M.L.; Puebla, A.M.; Delgado, J.I.; Alvarez, L. Cytotoxic Podophyllotoxin Type-Lignans from the Steam Bark of Bursera Fagaroides Var. Fagaroides. Molecules 2012, 17, 9506–9519. [Google Scholar] [CrossRef] [Green Version]
  61. Xu, F.; Jin, T.; Zhu, Y.; Dai, C. Immune Checkpoint Therapy in Liver Cancer. J. Exp. Clin. Cancer Res. 2018, 37, 110. [Google Scholar] [CrossRef] [Green Version]
  62. Li, X.; Ramadori, P.; Pfister, D.; Seehawer, M.; Zender, L.; Heikenwalder, M. The Immunological and Metabolic Landscape in Primary and Metastatic Liver Cancer. Nat. Rev. Cancer 2021, 21, 541–557. [Google Scholar] [CrossRef]
  63. Yang, W.S.; Zeng, X.F.; Liu, Z.N.; Zhao, Q.H.; Tan, Y.T.; Gao, J.; Li, H.L.; Xiang, Y.B. Diet and Liver Cancer Risk: A Narrative Review of Epidemiological Evidence. Br. J. Nutr. 2020, 124, 330–340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Daher, S.; Massarwa, M.; Benson, A.A.; Khoury, T. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. J. Clin. Transl. Hepatol. 2018, 6, 69–78. [Google Scholar] [CrossRef] [Green Version]
  65. Eshiet, E.R.; Zhu, J.; Anderson, T.A.; Smith, E.E. Chemical Characterization of B Rickellia Cavanillesii (A Steraceae) Using Gas Chromatographic Methods. Food Sci. Nutr. 2014, 2, 105–113. [Google Scholar] [CrossRef] [PubMed]
  66. Cilia-López, V.G.; Cariño-Cortés, R.; Zurita-Salinas, L.R. Ethnopharmacology of the Asteraceae Family in Mexico. Bot. Sci. 2021, 99, 455–486. [Google Scholar] [CrossRef]
  67. Viñas, R.; Smith, E.E. Preliminary Evaluation of Prodigiosa Herbal Tea: Cytotoxicity and GLUT2 Expression in HepG2 Cells. Toxicol. Environ. Chem. 2013, 95, 669–678. [Google Scholar] [CrossRef]
  68. Urias-Lugo, D.A.; Heredia, J.B.; Serna-Saldivar, S.O.; Muy-Rangel, M.D.; Valdez-Torres, J.B. Total Phenolics, Total Anthocyanins and Antioxidant Capacity of Native and Elite Blue Maize Hybrids (Zea Mays L.). CYTA—J. Food 2015, 13, 336–339. [Google Scholar] [CrossRef]
  69. Urias-Lugo, D.A.; Heredia, J.B.; Muy-Rangel, M.D.; Valdez-Torres, J.B.; Serna-Saldívar, S.O.; Gutiérrez-Uribe, J.A. Anthocyanins and Phenolic Acids of Hybrid and Native Blue Maize (Zea Mays L.) Extracts and Their Antiproliferative Activity in Mammary (MCF7), Liver (HepG2), Colon (Caco2 and HT29) and Prostate (PC3) Cancer Cells. Plant Foods Hum. Nutr. 2015, 70, 193–199. [Google Scholar] [CrossRef]
  70. Mena-Rejon, G.; Caamal-Fuentes, E.; Cantillo-Ciau, Z.; Cedillo-Rivera, R.; Flores-Guido, J.; Moo-Puc, R. In Vitro Cytotoxic Activity of Nine Plants Used in Mayan Traditional Medicine. J. Ethnopharmacol. 2009, 121, 462–465. [Google Scholar] [CrossRef]
  71. Orozco-Barocio, A.; Lizbeth Paniagua-Domínguez, B.; Alberto Benítez-Saldaña, P.; Flores-Torales, E.; Velázquez-Magaña, S.; Julieta, H.; Nava, A. Cytotoxic effect of the ethanolic extract of lophocereus schottii: A mexican medicinal plant. Afr. J. Tradit. Complement. Altern. Med. 2013, 10, 33–3777. [Google Scholar] [CrossRef]
  72. Merlín-Lucas, V.; Ordoñez-Razo, R.M.; Calzada, F.; Solís, A.; García-Hernández, N.; Barbosa, E.; Valdés, M. Antitumor Potential of Annona Muricata Linn. An Edible and Medicinal Plant in Mexico: In Vitro, in Vivo, and Toxicological Studies. Molecules 2021, 26, 7675. [Google Scholar] [CrossRef]
  73. Carrillo Mónica, G.; Callejas Gina Marcela, M.; Zambrano Crispin Astolfo, C.; Bravo Ricardo, V. Antiproliferative activity of total extracts from annona squamosa, petiveria alliacea and punica granatum on cancer cell lines. Pharmacologyonline 2020, 3, 7–18. [Google Scholar]
  74. Amran, N.; Rani, A.; Mahmud, R.; Yin, K. Antioxidant and Cytotoxic Effect of Barringtonia Racemosa and Hibiscus Sabdariffa Fruit Extracts in MCF-7 Human Breast Cancer Cell Line. Pharmacogn. Res. 2016, 8, 66–70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Chiu, C.T.; Chen, J.H.; Chou, F.P.; Lin, H.H. Hibiscus Sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF- ΚB/MMP-9 Pathway. Nutrients 2015, 7, 5065–5087. [Google Scholar] [CrossRef] [PubMed]
  76. Alonso-Castro, A.J.; Ortiz-Sánchez, E.; Domínguez, F.; Arana-Argáez, V.; Juárez-Vázquez, M.D.C.; Chávez, M.; Carranza-Álvarez, C.; Gaspar-Ramírez, O.; Espinosa-Reyes, G.; López-Toledo, G.; et al. Antitumor and Immunomodulatory Effects of Justicia Spicigera Schltdl (Acanthaceae). J. Ethnopharmacol. 2012, 141, 888–894. [Google Scholar] [CrossRef] [PubMed]
  77. Elghondakly, M.; Moawad, A.; Hetta, M. Cytotoxicity and Chromatographic Analysis of Dioon Spinulosum, Family Zamiaceae. J. Appl. Pharm. Sci. 2020, 10, 75–82. [Google Scholar] [CrossRef]
  78. Rodriguez-Garcia, A.; Peixoto, I.T.A.; Verde-Star, M.J.; de La Torre-Zavala, S.; Aviles-Arnaut, H.; Ruiz, A.L.T.G. In Vitro Antimicrobial and Antiproliferative Activity of Amphipterygium Adstringens. Evid.-Based Complement. Altern. Med. 2015, 2015, 175497. [Google Scholar] [CrossRef] [Green Version]
  79. Elizondo-Luévano, J.H.; Gomez-Flores, R.; Verde-Star, M.J.; Tamez-Guerra, P.; Romo-Sáenz, C.I.; Chávez-Montes, A.; Rodríguez-Garza, N.E.; Quintanilla-Licea, R. In Vitro Cytotoxic Activity of Methanol Extracts of Selected Medicinal Plants Traditionally Used in Mexico against Human Hepatocellular Carcinoma. Plants 2022, 11, 2862. [Google Scholar] [CrossRef]
  80. Nocedo-Mena, D.; Rivas-Galindo, V.M.; Navarro, P.; Garza-González, E.; González-Maya, L.; Ríos, M.Y.; García, A.; Ávalos-Alanís, F.G.; Rodríguez-Rodríguez, J.; del Rayo Camacho-Corona, M. Antibacterial and Cytotoxic Activities of New Sphingolipids and Other Constituents Isolated from Cissus Incisa Leaves. Heliyon 2020, 6, e04671. [Google Scholar] [CrossRef]
  81. Sánchez-Aguirre, O.A.; Juárez-Aguilar, E.; Montoya-Hernández, E.L.; Vázquez-Hernández, M.; Colorado-Peralta, R.; Sánchez-Medina, A.; Márquez-López, M.E.; Hernández-Romero, D. Antioxidant Potential of Cnidoscolus Multilobus (Pax) I.M. Johnst and Its Antiproliferative and Cytotoxic Effect on Cervical Cancer Cells. Eur. J. Integr. Med. 2022, 53, 102134. [Google Scholar] [CrossRef]
  82. Chel-Guerrero, L.D.; Scampicchio, M.; Ferrentino, G.; Rodríguez-Buenfil, I.M.; Fragoso-Serrano, M. In Vitro Assessment of Antiproliferative Activity and Cytotoxicity Modulation of Capsicum Chinense By-Product Extracts. Appl. Sci. 2022, 12, 5818. [Google Scholar] [CrossRef]
  83. Maldonado-Cubas, J.; San Martin-Martínez, E.; Quiroz-Reyes, C.N.; Casañas-Pimentel, R.G. Cytotoxic Effect of Semialarium Mexicanum (Miers) Mennega Root Bark Extracts and Fractions against Breast Cancer Cells. Physiol. Mol. Biol. Plants 2018, 24, 1185–1201. [Google Scholar] [CrossRef] [PubMed]
  84. Murillo-Alvarez, J.I.; Encarnación, D.R.; Franzblau, S.G. Antimicrobial and Cytotoxic Activity of Some Medicinal Plants from Baja California Sur (Mexico). Pharm. Biol. 2001, 39, 445–449. [Google Scholar] [CrossRef]
  85. Casillas, F.R.; Cardenas, A.O.; Rivas Morales, C.; Verde Star, M.J.; Cruz-Vega, D.E. Cytotoxic Activity of Agave Lechuguilla Torr. Afr. J. Biotechnol. 2012, 11, 12229–12231. [Google Scholar] [CrossRef]
  86. De La Torre Rodriguez, Y.C.; Estrada, F.R.M.; Suarez, A.E.F.; de Torres, N.W.; Aranda, R.S. Larvicidal and Cytotoxic Activities of Extracts from 11 Native Plants from Northeastern Mexico. J. Med. Entomol. 2013, 50, 310–313. [Google Scholar] [CrossRef]
  87. Escobedo Hinojosa, W.I.; Acevedo Quiróz, M.; Romero Álvarez, I.; Escobar Castañeda, P.; Villarreal, M.L.; Taketa, A.C. Anti-Helicobacter Pylori, Gastroprotective, Anti-Inflammatory, and Cytotoxic Activities of Methanolic Extracts of Five Different Populations of Hippocratea Celastroides Collected in Mexico. J. Ethnopharmacol. 2014, 155, 1156–1163. [Google Scholar] [CrossRef]
  88. Sianipar, M.P.; Suwarso, E.; Rosidah, R. Antioxidant and Anticancer Activities of Hexane Fraction from Carica Papaya l. Male Flower. Asian J. Pharm. Clin. Res. 2018, 11, 81–83. [Google Scholar] [CrossRef]
  89. Dalkılıç, S.; Korkmaz, İ.; Dalkılıç, L.K.; Akay, G.; Fidan, S. In Vitro Cytotoxic Effects of Smilax Aspera L. Roots on Cancer Cell Lines. Food Biosci. 2022, 46, 101501. [Google Scholar] [CrossRef]
  90. Datkhile, K.D.; Patil, S.R.; Patil, M.N.; Durgawale, P.P.; Jagdale, N.J.; Deshmukh, V.N. Studies on Phytoconstituents, in Vitro Antioxidant, Antibacterial, and Cytotoxicity Potential of Argemone Mexicana Linn. (Family: Papaveraceae). J. Nat. Sci. Biol. Med. 2020, 11, 198–205. [Google Scholar] [CrossRef]
  91. Guajardo-Flores, D.; Serna-Saldívar, S.O.; Gutiérrez-Uribe, J.A. Evaluation of the Antioxidant and Antiproliferative Activities of Extracted Saponins and Flavonols from Germinated Black Beans (Phaseolus Vulgaris L.). Food Chem. 2013, 141, 1497–1503. [Google Scholar] [CrossRef]
  92. Fan, A.; Wang, B.; Wang, X.; Nie, Y.; Fan, D.; Zhao, X.; Lu, Y. Immunotherapy in Colorectal Cancer: Current Achievements and Future Perspective. Int. J. Biol. Sci. 2021, 17, 3837–3849. [Google Scholar] [CrossRef]
  93. Eng, C.; Jácome, A.A.; Agarwal, R.; Hayat, M.H.; Byndloss, M.X.; Holowatyj, A.N.; Bailey, C.; Lieu, C.H. A Comprehensive Framework for Early-Onset Colorectal Cancer Research. Lancet Oncol. 2022, 23, e116–e128. [Google Scholar] [CrossRef] [PubMed]
  94. Andrade-Meza, A.; Arias-Romero, L.E.; Armas-López, L.; Ávila-Moreno, F.; Chirino, Y.I.; Delgado-Buenrostro, N.L.; García-Castillo, V.; Gutiérrez-Cirlos, E.B.; Juárez-Avelar, I.; Leon-Cabrera, S.; et al. Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies. Int. J. Mol. Sci. 2023, 24, 2115. [Google Scholar] [CrossRef] [PubMed]
  95. Zygulska, A.L.; Pierzchalski, P. Novel Diagnostic Biomarkers in Colorectal Cancer. Int. J. Mol. Sci. 2022, 23, 852. [Google Scholar] [CrossRef] [PubMed]
  96. Moran, K.L.; Bjorndal, K.A. Simulated Green Turtle Grazing Affects Nutrient Composition of the Seagrass Thalassia Testudinum. Mar. Biol. 2007, 150, 1083–1092. [Google Scholar] [CrossRef]
  97. Delgado-Roche, L.; González, K.; Mesta, F.; Couder, B.; Tavarez, Z.; Zavala, R.; Hernandez, I.; Garrido, G.; Rodeiro, I.; Vanden Berghe, W. Polyphenolic Fraction Obtained from Thalassia Testudinum Marine Plant and Thalassiolin B Exert Cytotoxic Effects in Colorectal Cancer Cells and Arrest Tumor Progression in a Xenograft Mouse Model. Front. Pharmacol. 2020, 11, 1939. [Google Scholar] [CrossRef]
  98. Rady, I.; Bloch, M.B.; Chamcheu, R.C.N.; Banang Mbeumi, S.; Anwar, M.R.; Mohamed, H.; Babatunde, A.S.; Kuiate, J.R.; Noubissi, F.K.; el Sayed, K.A.; et al. Anticancer Properties of Graviola (Annona Muricata): A Comprehensive Mechanistic Review. Oxid. Med. Cell. Longev. 2018, 2018, 1826170. [Google Scholar] [CrossRef] [Green Version]
  99. Daddiouaissa, D.; Amid, A.; Abdullah Sani, M.S.; Elnour, A.A.M. Evaluation of Metabolomics Behavior of Human Colon Cancer HT29 Cell Lines Treated with Ionic Liquid Graviola Fruit Pulp Extract. J. Ethnopharmacol. 2021, 270, 113813. [Google Scholar] [CrossRef]
  100. Zorofchian Moghadamtousi, S.; Karimian, H.; Rouhollahi, E.; Paydar, M.; Fadaeinasab, M.; Abdul Kadir, H. Annona Muricata Leaves Induce G1 Cell Cycle Arrest and Apoptosis through Mitochondria-Mediated Pathway in Human HCT-116 and HT-29 Colon Cancer Cells. J. Ethnopharmacol. 2014, 156, 277–289. [Google Scholar] [CrossRef]
  101. Abbas, E.Y.; Ezzat, M.I.; el Hefnawy, H.M.; Abdel-Sattar, E. An Overview and Update on the Chemical Composition and Potential Health Benefits of Opuntia Ficus-Indica (L.) Miller. J. Food Biochem. 2022, 46, e14310. [Google Scholar] [CrossRef]
  102. Silva, M.A.; Albuquerque, T.G.; Pereira, P.; Ramalho, R.; Vicente, F.; Oliveira, M.B.P.P.; Costa, H.S. Opuntia Ficus-Indica (L.) Mill.: A Multi-Benefit Potential to Be Exploited. Molecules 2021, 26, 951. [Google Scholar] [CrossRef]
  103. Antunes-Ricardo, M.; Hernández-Reyes, A.; Uscanga-Palomeque, A.C.; Rodríguez-Padilla, C.; Martínez-Torres, A.C.; Gutiérrez-Uribe, J.A. Isorhamnetin Glycoside Isolated from Opuntia Ficus-Indica (L.) MilI Induces Apoptosis in Human Colon Cancer Cells through Mitochondrial Damage. Chem. Biol. Interact. 2019, 310, 108734. [Google Scholar] [CrossRef] [PubMed]
  104. Antunes-Ricardo, M.; Moreno-García, B.E.; Gutiérrez-Uribe, J.A.; Aráiz-Hernández, D.; Alvarez, M.M.; Serna-Saldivar, S.O. Induction of Apoptosis in Colon Cancer Cells Treated with Isorhamnetin Glycosides from Opuntia Ficus-Indica Pads. Plant Foods Hum. Nutr. 2014, 69, 331–336. [Google Scholar] [CrossRef] [PubMed]
  105. Antunes-Ricardo, M.; Guardado-Félix, D.; Rocha-Pizaña, M.R.; Garza-Martínez, J.; Acevedo-Pacheco, L.; Gutiérrez-Uribe, J.A.; Villela-Castrejón, J.; López-Pacheco, F.; Serna-Saldívar, S.O. Opuntia Ficus-Indica Extract and Isorhamnetin-3-O-Glucosyl-Rhamnoside Diminish Tumor Growth of Colon Cancer Cells Xenografted in Immune-Suppressed Mice through the Activation of Apoptosis Intrinsic Pathway. Plant Foods Hum. Nutr. 2021, 76, 434–441. [Google Scholar] [CrossRef] [PubMed]
  106. Moga, A.; Dimienescu, O.G.; Balan, A.; Dima, L.; Toma, S.I.; Bîgiu, N.F.; Blidaru, A. Pharmacological and Therapeutic Properties of Punica Granatum Phytochemicals: Possible Roles in Breast Cancer Marius. Molecules 2021, 26, 1054. [Google Scholar] [CrossRef]
  107. Cortez-Trejo, M.C.; Olivas-Aguirre, F.J.; Dufoo-Hurtado, E.; Castañeda-Moreno, R.; Villegas-Quintero, H.; Medina-Franco, J.L.; Mendoza, S.; Wall-Medrano, A. Potential Anticancer Activity of Pomegranate (Punica Granatum L.) Fruits of Different Color: In Vitro and In Silico Evidence. Biomolecules 2022, 12, 1649. [Google Scholar] [CrossRef]
  108. Rodrigues, C.A.; Nicácio, A.E.; Boeing, J.S.; Garcia, F.P.; Nakamura, C.V.; Visentainer, J.V.; Maldaner, L. Rapid Extraction Method Followed by a D-SPE Clean-up Step for Determination of Phenolic Composition and Antioxidant and Antiproliferative Activities from Berry Fruits. Food Chem. 2020, 309, 125694. [Google Scholar] [CrossRef]
  109. Forman, H.J.; Zhang, H. Targeting Oxidative Stress in Disease: Promise and Limitations of Antioxidant Therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef]
  110. Maiuolo, J.; Gliozzi, M.; Carresi, C.; Musolino, V.; Oppedisano, F.; Scarano, F.; Nucera, S.; Scicchitano, M.; Bosco, F.; Macri, R.; et al. Nutraceuticals and Cancer: Potential for Natural Polyphenols. Nutrients 2021, 13, 3834. [Google Scholar] [CrossRef]
  111. Annaji, M.; Poudel, I.; Boddu, S.H.S.; Arnold, R.D.; Tiwari, A.K.; Babu, R.J. Resveratrol-Loaded Nanomedicines for Cancer Applications. Cancer Rep. 2021, 4, e1353. [Google Scholar] [CrossRef]
  112. Merlin, J.P.J.; Rupasinghe, H.P.V.; Dellaire, G.; Murphy, K. Role of Dietary Antioxidants in P53-Mediated Cancer Chemoprevention and Tumor Suppression. Oxid. Med. Cell. Longev. 2021, 2021, 9924328. [Google Scholar] [CrossRef]
Pharmaceuticals 16 00482 g001 550
Figure 1. Process of antioxidant extraction and characterization and principal phenolic compound present in Mexican medicinal plants.
Figure 1. Process of antioxidant extraction and characterization and principal phenolic compound present in Mexican medicinal plants.
Pharmaceuticals 16 00482 g001
Pharmaceuticals 16 00482 g002 550
Figure 2. Mexican medicinal plants used for the treatment of different types of cancer. The images were taken from the World Checklist of Selected Plant Families, WCSP record.
Figure 2. Mexican medicinal plants used for the treatment of different types of cancer. The images were taken from the World Checklist of Selected Plant Families, WCSP record.
Pharmaceuticals 16 00482 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Soto, K.M.; Pérez Bueno, J.d.J.; Mendoza López, M.L.; Apátiga-Castro, M.; López-Romero, J.M.; Mendoza, S.; Manzano-Ramírez, A. Antioxidants in Traditional Mexican Medicine and Their Applications as Antitumor Treatments. Pharmaceuticals 2023, 16, 482. https://doi.org/10.3390/ph16040482

AMA Style

Soto KM, Pérez Bueno JdJ, Mendoza López ML, Apátiga-Castro M, López-Romero JM, Mendoza S, Manzano-Ramírez A. Antioxidants in Traditional Mexican Medicine and Their Applications as Antitumor Treatments. Pharmaceuticals. 2023; 16(4):482. https://doi.org/10.3390/ph16040482

Chicago/Turabian Style

Soto, Karen M., José de Jesús Pérez Bueno, Maria Luisa Mendoza López, Miguel Apátiga-Castro, José M. López-Romero, Sandra Mendoza, and Alejandro Manzano-Ramírez. 2023. "Antioxidants in Traditional Mexican Medicine and Their Applications as Antitumor Treatments" Pharmaceuticals 16, no. 4: 482. https://doi.org/10.3390/ph16040482

APA Style

Soto, K. M., Pérez Bueno, J. d. J., Mendoza López, M. L., Apátiga-Castro, M., López-Romero, J. M., Mendoza, S., & Manzano-Ramírez, A. (2023). Antioxidants in Traditional Mexican Medicine and Their Applications as Antitumor Treatments. Pharmaceuticals, 16(4), 482. https://doi.org/10.3390/ph16040482

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop